IFF’s Designed Enzymatic Biomaterials™ Platform Sees First Large-Scale Use in Home Care Applications
(NYSE:IFF) NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced the first large-scale commercial use of its Designed Enzymatic Biomaterials™ (DEB) platform, as a major consumer packaged goods (CPG) company has launched a new laundry detergent formulation enhanced by DEB technology. The formulation delivers improved fabric softness and cleaning performance while replacing non-biodegradable ingredients with a readily biodeg
Related Questions
What is the expected margin impact of replacing non‑biodegradable ingredients with DEB technology in the newly launched detergent formulation?
Could this partnership with a major CPG company provide IFF a competitive edge over rivals in the enzymatic biomaterials space, and how might that affect its market share?
How will the large‑scale adoption of IFF’s DEB platform influence IFF’s upcoming quarterly earnings and revenue guidance?